Jaundice: Clinical Trials

6 trials for Jaundice, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 21Completed 1

Follow Jaundice: new trials by email Literature Review of Jaundice trials Research Report on Jaundice

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Remaxol® in Mechanical Jaundice of Non-malignant Origin
Remaxol (succinate + methionine + inosine + nicotinamide), Ringer's Solution - Jaundice, Obstructive
Phase 3CompletedPOLYSAN Scientific & Technological Pharmaceutical Company3422017-04-032020-07-14
Remaxol® in Malignant Mechanical Jaundice
Remaxol®, Ringer's Solution - Jaundice; Malignant
Phase 3CompletedPOLYSAN Scientific & Technological Pharmaceutical Company2402017-04-032020-07-10
The Effects of Dexamethasone Administration on Jaundice Following Liver Resection
Dexamethasone - Liver Dysfunction, Hepatectomy
Phase 2 / Phase 3CompletedShanghai Zhongshan Hospital762016-06-012021-06-10
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
AMG 479, Placebo, gemcitabine - Adenocarcinoma of the Pancreas, Advanced Solid Tumors
Phase 3CompletedNantCell, Inc.8002011-04-072024-07-16
Transcutaneous Bilirubinometry in Healthy Term and Near-Term Neonates
BiliChek (jaundice assessment), Transcutaneous bilirubinometry (TcB), Clinical asessment of bilirubin (CaB) - Hyperbilirubinemia
Phase 3CompletedAll India Institute of Medical Sciences6172006-11-012008-04-07
Improving Health Outcomes for New Mothers and Babies
Home Nurse Visit - Hyperbilirubinemia, Jaundice
Phase 3CompletedMilton S. Hershey Medical Center11542006-09-012017-07-28

Narrower conditions

Hyperbilirubinemia (3)  ·  Jaundice, Obstructive (2)  ·  Breast Feeding (1)  ·  Dehydration (1)  ·  Depression, Postpartum (1)  ·  Endocrine Gland Neoplasms (1)  ·  Liver Diseases (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Signs and Symptoms (6)  ·  Skin Manifestations (6)  ·  Hyperbilirubinemia (3)  ·  Digestive System Diseases (2)  ·  Behavior (1)  ·  Depressive Disorder (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Feeding Behavior (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Mental Disorders (1)  ·  Metabolic Diseases (1)

Interventions

Inosine (2)  ·  Methionine (2)  ·  Niacinamide (2)  ·  Remaxol (2)  ·  Ringer's Solution (2)  ·  Succinic Acid (2)  ·  Dexamethasone (1)  ·  Gemcitabine (1)  ·  dexamethasone 21-phosphate (1)  ·  ganitumab (1)

Sponsors

POLYSAN Scientific & Technological Pharmaceutical Company (2)  ·  All India Institute of Medical Sciences (1)  ·  Milton S. Hershey Medical Center (1)  ·  NantCell, Inc. (1)  ·  Shanghai Zhongshan Hospital (1)

Countries

Russia (3)  ·  United States (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)

Top investigators

Mikhail S. Bogomolov, MD, PhD (2)  ·  Hui-Chuan Sun, MD (1)  ·  Ian M Paul, MD, MSc (1)  ·  Satish Mishra, DM (1)

Results publications

PMID 11231856, PMID 19811459, PMID 20940288, PMID 22064874, PMID 23215909, PMID 23460682, PMID 24224656, PMID 25549051, PMID 26176387